Eclipse Technology Solutions

InfraScan Inc introduces the Infrascanner 2000, a portable screening device using (NIR) Near-Infrared technology to detect intracranial bleeding in patients which is beneficial to identifying intermediate referral to a CT scan and neurological intervention. The Infrascanner has been deployed as a standard component in trauma kits for all battalion aid stations by the US Marine Corps, marking a significant milestone in the application of the world's only handheld brain hematoma detective device. Now, for the first time ever, can be applied in a portable, handheld, FDA-cleared. CE marked device that empowers physicians to detect what's happening inside a human skull. Contact InfraScan Inc to learn more.

Lancaster Laboratories provides comprehensive analytical services in chemistry and microbiology to pharmaceutical and environmental clients worldwide. Founded in 1961, the company is one of the largest single-site commercial testing labs in the United States. With a strong industry reputation, Lancaster Laboratories serves many Fortune 500 industrial companies and nine of the 10 largest pharmaceutical companies in the world. Lancaster Laboratories was founded by Dr. Earl H. Hess to provide high quality analytical services to area agribusinesses and industries with personal attention to client needs. Nourished in a culture of quality, service and caring about all those associated with the business, the company became an industry leader known for innovative business practices and people-friendly policies.

Quotient Biodiagnostics is a commercial-stage in-vitro diagnostics company based in Newtown, PA. They are dedicated to developing cutting-edge solutions that accelerate and transform disease detection and diagnosis for patients and physicians. With a focus on growth and expansion in clinical diagnostics, their innovative products, such as Alba reagents for blood transfusion and the MosaiQ solution, aim to provide efficient screening, simplify diagnostic pathways, and deliver quick comprehensive diagnostic results, ultimately shortening time to diagnosis and treatment. As autoimmune and allergy cases continue to rise globally, Quotient Biodiagnostics aims to meet the increasing demand for efficient screening and better lab workflows. Their MosaiQ solution not only simplifies specialty testing in clinical labs but also creates the possibility for simultaneous rapid testing on the same platform, offering clinical and economical value for customers. With a market-leading testing portfolio in autoimmunity and plans to expand into attractive adjacencies, Quotient Biodiagnostics is committed to providing innovative diagnostic solutions that improve patient outcomes and enhance the efficiency of healthcare providers worldwide.Generated from the website